Evaluation of the efficacy of nicotine in treatment of allergic asthma in BALB/c mice
- 1 October 2018
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 63, 239-245
Abstract
No abstract availableKeywords
Funding Information
- Iran National Science Foundation (94012329)
This publication has 32 references indexed in Scilit:
- Vitexin inhibits inflammation in murine ovalbumin-induced allergic asthmaBiomedicine & Pharmacotherapy, 2018
- Asthma biomarkers in the age of biologicsAllergy, Asthma & Clinical Immunology, 2017
- Association of imbalance of effector T cells and regulatory cells with the severity of asthma and allergic rhinitis in childrenAllergy and Asthma Proceedings, 2017
- Illicium verum Extract and Trans-Anethole Attenuate Ovalbumin-Induced Airway Inflammation via Enhancement of Foxp3+ Regulatory T Cells and Inhibition of Th2 Cytokines in MiceMediators of Inflammation, 2017
- Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderlyClinical and Molecular Allergy, 2015
- Type 2 inflammation in asthma — present in most, absent in manyNature Reviews Immunology, 2014
- The immunology of asthmaNature Immunology, 2014
- Asthma phenotypes: the evolution from clinical to molecular approachesNature Medicine, 2012
- Functions of T cells in asthma: more than just TH2 cellsNature Reviews Immunology, 2010
- Asthma prevalence in 1973, 1988 and 2003Thorax, 2006